ArticleMedicine2025
Assessing the causal relationship between obesity and ankylosing spondylitis: A two-sample Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to explore the potential causal relationship between obesity and ankylosing spondylitis (AS) using the Mendelian randomization (MR) approach. Data were derived from a comprehensive genome-wide association study dataset. Genetic loci that demonstrated significant, independent associations with both obesity and AS in populations of European ancestry were selected as instrumental variables. Multiple MR analyses, including MR-Egger, weighted median, and inverse variance weighting, were employed to assess the causal impact of obesity on AS risk. To ensure reliability, heterogeneity, and multiplicity tests were conducted, and the robustness of the findings was evaluated through sensitivity analyses using the "leave-one-out" method. The inverse variance weighting analysis revealed an odds ratio (OR) of 0.95 with a 95% confidence interval of 0.76 to 1.19 and a P value of .653. These results indicated no significant causal link between obesity and AS development. Additionally, the heterogeneity and multiplicity tests showed no significant findings, while sensitivity analyses reinforced the consistency and robustness of the conclusions. This research did not find evidence of a causal relationship between obesity and the development of AS based on two-sample MR analysis and genetic data evaluation. However, the current study's limitations, including sample size and study design, highlight the need for future research with larger cohorts to further explore the intricate relationship between obesity and AS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.